Skip to main content
Clinical Trials/NL-OMON33101
NL-OMON33101
Recruiting
N/A

The assessment of microvascular alterations in renal-pancreas transplant recipients before and after transplantation. - OPS-2

eids Universitair Medisch Centrum0 sites15 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
diabetic nephropathy
Sponsor
eids Universitair Medisch Centrum
Enrollment
15
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Age: 18 \-70 years
  • 2\. Female or male
  • 3\. Kidney\-pancreas transplantation
  • 4\. Patients must be able to adhere to the study visit schedule and protocol requirements.
  • 5\. Patients must be able to give informed consent and the consent must be obtained prior to any study procedure.

Exclusion Criteria

  • 1\. Patients with evidence of active infection or abcesses
  • 2\. Patients suffering from hepatic failure.
  • 3\. Patients suffering from an active autoimmune disease
  • 4\. Patients with epilepsy
  • 5\. Malignancy (including lymphoproliferative disease) within the past 2\-5 years (except for squamous or basal cell carcinoma of the skin that has been treated with no evidence of recurrence).
  • 6\. Subjects who currently have an active opportunistic infection (e.g., herpes zoster \[shingles], cytomegalovirus (CMV), Pneumocystis carinii (PCP), aspergillosis, histoplasmosis, or mycobacteria other than TB)

Outcomes

Primary Outcomes

Not specified

Similar Trials